The Erasmus+ International Master in Innovative Medicine (IMIM) is a two-year 120 ECTS, English-taught, master of excellence programme, which focuses on the education of tomorrow’s leading translational biomedical researchers. The IMIM mission is to educate this future generation of translational scientists and professionals and to equip them with the skills and competences to excel in a wide range of multi- and interdisciplinary, internationally competitive academic and private sector environments.
IMIM is jointly organised by three European Top 100 Universities: the University of Groningen in the Netherlands, the Ruprecht-Karls-Universität Heidelberg in Germany and Uppsala Universitet in Sweden. IMIM students will benefit from the vast wealth of resources and staff experience that these three universities have to offer in the biomedical sciences, as well as from their networks within both the academic and private sectors.
In IMIM, students will follow tailor-made training programmes at at least two of the three European universities and will have the further opportunity to undertake research at one of IMIM’s private sector industry partners or one of the programme’s Latin American partner institutions, those being: Universidade de São Paulo in Brazil, Pontificia Universidad Católica de Chile in Chile, Universidad de Antioquia in Colombia, and Universidad Nacional Autónoma de México in Mexico.
Alongside their courses and research projects, students will also be involved in a Bench to Bedside and Back (BBB) translational project throughout the four semesters of IMIM, focused on the idea of bringing science to society. This multidisciplinary group project is designed to encourage the growth of students’ business and entreprenuerial skills. On top of this, students will take part in the IMIM Spring and Summer Schools, respectively designed to develop the students' soft skills and business savvy!